Choreo LLC’s Gossamer Bio GOSS Stock Holding History

Choreo LLC’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$88.9K	Buy	540,111 +290,000	+116%	+$80.9K	﹤0.01%	1620
2026 Q1	$82.2K	Buy	250,111 +175,000	+233%	+$275K	﹤0.01%	1550
2025 Q4	$234K	Sell	75,111 -10,000	-12%	-$28.5K	﹤0.01%	1367
2025 Q3	$224K	Buy	85,111 +9,000	+12%	+$19.8K	﹤0.01%	1393
2025 Q2	$93.6K	Buy	76,111 +28,000	+58%	+$30.5K	﹤0.01%	1467
2025 Q1	$52.9K	Hold	48,111	–	–	﹤0.01%	1398
2024 Q4	$43.5K	Hold	48,111	–	–	﹤0.01%	1546
2024 Q3	$50.5K	Hold	48,111	–	–	﹤0.01%	1567
2024 Q2	$45.6K	Buy	+48,111	New	+$36K	﹤0.01%	1447

Other funds holding GOSS

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

DIG

DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

Choreo LLC's GOSS Position: Q2 2026 in Review

Choreo LLC increased its Gossamer Bio (GOSS) stake by 116% in Q2 2026, buying an estimated $80.9K and bringing the position to 540,111 shares worth $88.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1620.

Choreo LLC first reported a position in GOSS in Q2 2024 and has held it in 9 quarters since. The position peaked at $234K in Q4 2025. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

Choreo LLC held 540,111 shares of Gossamer Bio worth $88.9K as of Q2 2026.
Choreo LLC bought 290,000 Gossamer Bio shares in Q2 2026, an estimated $80.9K.
Gossamer Bio made up ﹤0.01% of Choreo LLC's portfolio in Q2 2026, its #1620 holding.
Choreo LLC first reported a position in Gossamer Bio in Q2 2024 and has held it in 9 quarters since.
Choreo LLC's Gossamer Bio position peaked at $234K in Q4 2025.
170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.